I. Biasoli, A. Stamatoullas, and V. Meignin, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group, Cancer, vol.116, issue.3, pp.631-639, 2010.

M. Al-mansour, J. M. Connors, R. D. Gascoyne, B. Skinnider, and K. J. Savage, Transformation to Aggressive Lymphoma in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma, J Clin Oncol, vol.28, issue.5, pp.793-799, 2010.

R. H. Advani, S. J. Horning, and R. T. Hoppe, Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte-Predominant Hodgkin Lymphoma, J Clin Oncol, vol.32, issue.9, pp.912-918, 2014.

T. A. Eyre, K. Gatter, G. P. Collins, G. W. Hall, C. Watson et al., Incidence, management and outcome of high grade transformation of nodular lymphocyte predominant Hodgkin lymphoma: long-term outcomes from a 30-year experience, Am J Hematol, vol.90, issue.6, pp.103-110, 2015.

D. A. Eichenauer, A. Engert, and M. André, Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.25, issue.3, pp.70-75, 2014.

, The National Comprehensive Cancer Network

V. Diehl, M. Sextro, and J. Franklin, Clinical Presentation, Course, and Prognostic Factors in Lymphocyte-Predominant Hodgkin's Disease and Lymphocyte-Rich Classical Hodgkin's Disease: Report From the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease, J Clin Oncol, vol.17, issue.3, pp.776-783, 1999.

L. Nogová, T. Reineke, and C. Brillant, Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group, J Clin Oncol, vol.26, issue.3, pp.434-439, 2008.

N. K. Gerber, C. L. Atoria, E. B. Elkin, and J. Yahalom, Characteristics and Outcomes of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Versus Those With Classical Hodgkin Lymphoma: A Population-Based Analysis, Int J Radiat Oncol Biol Phys, vol.92, issue.1, pp.76-83, 2015.

S. Hartmann, D. A. Eichenauer, and A. Plütschow, The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

, Blood, vol.122, issue.26, pp.4246-4252, 2013.

B. Pellegrino, M. J. Terrier-lacombe, and O. Oberlin, Lymphocyte-Predominant Hodgkin's Lymphoma in Children: Therapeutic Abstention After Initial Lymph Node Resection--A Study of the French Society of Pediatric Oncology, J Clin Oncol, vol.21, issue.15, pp.2948-2952, 2003.

C. Mauz-körholz, S. Gorde-grosjean, and D. Hasenclever, Resection alone in 58 children with limited stage, lymphocytepredominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma, Cancer, vol.110, issue.1, pp.179-185, 2007.

R. B. Wilder, P. J. Schlembach, and D. Jones, Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease, Cancer, vol.100, issue.12, pp.1731-1738, 2002.

A. Wirth, K. Yuen, and M. Barton, Longterm outcome after radiotherapy alone for lymphocyte-predominant Hodgkin lymphoma, Cancer, vol.104, issue.6, pp.1221-1229, 2005.

D. A. Eichenauer, A. Plütschow, and M. Fuchs, Long-term course of patients with stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a Report from the German Hodgkin Study Group, J Clin Oncol, vol.33, issue.26, pp.2857-62, 2015.

L. Nogova, T. Reineke, and H. T. Eich, Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG), Ann Oncol, vol.16, issue.10, pp.1683-1687, 2005.

R. C. Chen, M. S. Chin, and A. K. Ng, Earlystage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long followup, J Clin Oncol, vol.28, issue.1, pp.136-141, 2010.

K. J. Savage, B. Skinnider, M. Al-mansour, L. H. Sehn, R. D. Gascoyne et al., Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome, Blood, vol.118, issue.17, pp.4585-4590, 2011.

K. H. Xing, J. M. Connors, and A. Lai, Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis, Blood, vol.123, issue.23, pp.3567-3573, 2014.

G. P. Canellos and P. Mauch, What Is the Appropriate Systemic Chemotherapy for Lymphocyte-Predominant Hodgkin's Lymphoma?, J Clin Oncol, vol.28, issue.1, pp.8-8, 2010.

M. A. Fanale, C. M. Lai, and P. Mclaughlin, Outcomes of Nodular Lymphocyte Predominant Hodgkin's Lymphoma (NLPHL) Patients Treated with R-CHOP

, ASH Meeting, 2010.

D. A. Eichenauer, M. Fuchs, and A. Pluetschow, Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocytepredominant Hodgkin lymphoma: a report from the German Hodgkin Study Group, Blood, vol.118, issue.16, pp.4363-4365, 2011.

R. H. Advani and R. T. Hoppe, How I treat nodular lymphocyte predominant Hodgkin lymphoma, Blood, vol.122, issue.26, pp.4182-4188, 2013.

K. H. Xing and K. J. Savage, Modern Management of Lymphocyte Predominant Hodgkin Lymphoma, Br J Haematol, vol.161, issue.3, pp.316-329, 2013.

H. Schulz, U. Rehwald, and F. Morschhauser, Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG), Blood, vol.111, issue.1, pp.109-111, 2008.

M. Karuturi, C. Hosing, and M. Fanale, High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Nodular Lymphocyte-Predominant Hodgkin Lymphoma, Biol Blood Marrow Transplant, vol.19, issue.6, pp.991-994, 2013.